Search by Drug Name or NDC
NDC 51672-2131-04 Childrens Loratadine 5 mg/5mL Details
Childrens Loratadine 5 mg/5mL
Childrens Loratadine is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is LORATADINE.
MedlinePlus Drug Summary
Loratadine is used to temporarily relieve the symptoms of hay fever (allergy to pollen, dust, or other substances in the air) and other allergies. These symptoms include sneezing, runny nose, and itchy eyes, nose, or throat. Loratadine is also used to treat itching and redness caused by hives. However, loratadine does not prevent hives or other allergic skin reactions. Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Loratadine is also available in combination with pseudoephedrine (Sudafed, others). This monograph only includes information about the use of loratadine alone. If you are taking the loratadine and pseudoephedrine combination product, read the information on the package label or ask your doctor or pharmacist for more information.
Related Packages: 51672-2131-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Loratadine
Product Information
| NDC | 51672-2131 |
|---|---|
| Product ID | 51672-2131_7f289479-6ec5-49c3-b724-851e90c68264 |
| Associated GPIs | 41550030001220 |
| GCN Sequence Number | 018697 |
| GCN Sequence Number Description | loratadine SOLUTION 5 MG/5 ML ORAL |
| HIC3 | Z2Q |
| HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
| GCN | 60562 |
| HICL Sequence Number | 007605 |
| HICL Sequence Number Description | LORATADINE |
| Brand/Generic | Generic |
| Proprietary Name | Childrens Loratadine |
| Proprietary Name Suffix | Sugar Free |
| Non-Proprietary Name | Loratadine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/5mL |
| Substance Name | LORATADINE |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076805 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51672-2131-04 (51672213104)
| NDC Package Code | 51672-2131-4 |
|---|---|
| Billing NDC | 51672213104 |
| Package | 1 BOTTLE in 1 CARTON (51672-2131-4) / 60 mL in 1 BOTTLE |
| Marketing Start Date | 2017-03-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |